Sterile products occupy an important position in the production of clinical and pharmaceutical industries. The domestic and foreign drug regulatory agencies have always maintained a high-pressure supervision over their R&D and production. Based on the extreme importance of pollution control. The European Pharmacopoeia has recently passed a major revision of the injection monograph, which will be implemented on July 1, 2021. Under the new situation, it is imperative that sterile drugs implement mandatory higher pollution control technical requirements. VSUN was invited as the leading company in sterile filling procedure and attended the Sterile Product Contamination Control Strategy Summit in Shanghai from Nov. 26-28. During the seminar, VSUN introduced our new aspects of aseptic filling control method. VSUN BFS specialist speaker was invited to give an asepetic filling technology case studies speech. The key points for BFS technology model selection were discussed during the seminar. The seminar was held in Shanghai, China and attended by over 100 participants, including decision makers, consultants, engineers, plant operators, service providers, researchers and government officers from all over Chinese pharmaceutical industry. The participants expressed a high level of interest in the technology presented during the seminar’s Q &A session.